Hint mode is switched on Switch off
For swift navigation between sections

Organization: Santhera Pharmaceuticals
LEI 54930035HAOFTTQH0U85

Organization name
Santhera Pharmaceuticals Holding AG
Country name
Switzerland
Country of registration
Switzerland
Industry
Pharmaceutical Preparation and Biotechnology
Bond debt
21 mln USD

explore the most comprehensive database

800 000

bonds globally

Over 400

pricing sources

80 000

stocks

9 000

ETF

track your portfolio in the most efficient way
Bond Search
Watchlist
Excel ADD-IN
Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 700 000 bonds, stocks & ETFs; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Latest data on

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Santhera Pharmaceuticals is a Swiss drug discovery and development company. It is focused on the development of treatments for neuromuscular and neuro-ophthalmological diseases that currently lack treatment options. The company was founded in 2004 through the merger of two start-up biotech companies, MyoContract and Graffinity Pharmaceuticals. Santhera’s headquarters are located in Liestal, Switzerland, with subsidiaries in Germany, UK, Italy, Netherlands, Liechtenstein, US and Canada.

Awards

Documentation

Stocks

Latest issues

Show all

Bond debt by currency

Show more Hide

Codes

  • LEI
    54930035HAOFTTQH0U85
  • SIC
    2834 PHARMACEUTICAL PREPARATIONS

Credit and ESG Ratings

Macroeconomic Indicators - Santhera Pharmaceuticals

Registration is required to get access.